Abstract PR14: Phase I trial of first-in-class ataxia telangiectasia-mutated and Rad3-related (ATR) inhibitor VX-970 as monotherapy (mono) or in combination with carboplatin (CP) i... von Yap, Timothy A., Luken, Maria J. de Miguel, O'Carrigan, Brent, Roda, Desam, Papadatos-Pastos, Dionysis, Lorente, David, Tunariu, Nina, Lopez, Raquel Perez, Gayle, Sasha, Riisnaes, Ruth, Figueiredo, Ines, Miranda, Susana, Carreira, Suzanne, Yang, Fang, Karan, Sharon, Penney, Marina, Pollard, John, Molife, L. Rhoda, Banerji, Udai, Asmal, Mohammed, Fields, Scott Z., Bono, Johann S. de

Volltext

Immune modulation and the oral live biotherapeutic product, MRx0518, in treatment-naïve patients with cancer: Updated safety data von Lythgoe, Mark, Dama, Paola, Frampton, Adam Enver, Pickford, Emily, Tookman, Laura, Cunnea, Paula, Fotopoulou, Christina, Liu, Daniel, Clark, James, Lozano-kuehne, Jingky, Badman, Philip David, Clarke, Aaron, Chetal, Sasha, Fyvie, Gayle, Stevenson, Alex, Krell, Jonathan

Volltext

Unexplained Respiratory Disease Outbreak Working Group Activities — Worldwide, March 2007–September 2011 von Cieslak, Paul R, Britt, April S, Hicks, Lauri, Conklin, Laura, Van Beneden, Chris, Garrison, Laurel E, Winchell, Jonas, Schneider, Eileen, Erdman, Dean, Fry, Alicia, Jain, Seema, Uyeki, Tim, Finelli, Lyn, Lindstrom, Steve, Clark, Thomas A, Tondella, Maria-Lucia, Shieh, Wun-Ju, Zaki, Sherif, Fleming-Dutra, Katherine E

Volltext